Universal Health Services, Inc.
UHS Healthcare Medical Care Facilities
Universal Health Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $17.4 billion, up 9.71% from fiscal 2024.
- Revenue
- +5.30%
- EPS
- −9.98%
- Free cash flow
- +216.7%
- Total debt
- +21.7%
Quarter to September 2026, against a year earlier
Follow UHS
Alert me
Universal Health Services, Inc. (UHS) EV/EBITDA
As of 5 November 2026, Universal Health Services, Inc. (UHS) trades at a EV/EBITDA of 6.4×. Over the past ten years it has ranged from 4.9× (July 2026) to 11.5× (June 2015); the current reading is higher than 6% of that period. That is below the Medical Care Facilities industry median of 11.9× and below the Healthcare sector median of 8.4×.
EV/EBITDA, daily
Embed this chart
Annual newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| FY2025 | 7.1× | (1.78%) |
| FY2024 | 7.2× | (19.72%) |
| FY2023 | 9.0× | (6.04%) |
| FY2022 | 9.5× | 22.51% |
| FY2021 | 7.8× | 1.62% |
| FY2020 | 7.7× | (21.46%) |
| FY2019 | 9.8× | 7.65% |
| FY2018 | 9.1× | 4.31% |
| FY2017 | 8.7× | 1.98% |
| FY2016 | 8.5× | (6.86%) |
Quarterly newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| Sep 2026 | 5.8× | 16.20% |
| Jun 2026 | 5.0× | (13.50%) |
| Mar 2026 | 5.8× | (17.74%) |
| Dec 2025 | 7.1× | 3.38% |
| 43 more quarters | Free account |
Against its own ten years
EV/EBITDA against peers
| Company | EV/EBITDA |
|---|---|
| THC Tenet Healthcare Corporation compare | 4.7× |
| FMS Fresenius Medical Care AG & Co. KGaA compare | 5.1× |
| UHS Universal Health Services, Inc. | 6.4× |
| DVA DaVita Inc. compare | 8.0× |
| EHC Encompass Health Corporation compare | 10.7× |
| CON Concentra Group Holdings Parent, Inc. compare | 14.0× |
| PACS PACS Group, Inc. compare | 16.2× |
| CHE Chemed Corporation compare | 16.3× |
| ENSG The Ensign Group, Inc. compare | 16.4× |
| Medical Care Facilities industry median | 11.9× |
| Healthcare sector median | 8.4× |
| Market median | 10.9× |
What EV/EBITDA is
Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)
More on UHS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement